ETOPOSIDE TEVA Izrael - angličtina - Ministry of Health

etoposide teva

abic marketing ltd, israel - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - etoposide - etoposide - hodgkin's disease. malignant (non-hodgkin's) lymphomas, especially of the histiocytic variety.acute non-lymphocytic leukemia. management of refractory testicular tumors and of small cell lung cancer.

ROMIPLATE POWDER FOR SOLUTION FOR INJECTION 250 μgvial Singapur - angličtina - HSA (Health Sciences Authority)

romiplate powder for solution for injection 250 μgvial

kyowa kirin asia pacific pte. ltd. - romiplostim 375 μg/vial - injection, powder, for solution - romiplostim 375μg/vial (deliverable amt 250μg/vial) - romiplostim 375 μg/vial 250 μg/vial (deliverable amount)

PRECEDEX CONCENTRATE FOR SOLUTION FOR INFUSION 100 mcgml (Vial) Singapur - angličtina - HSA (Health Sciences Authority)

precedex concentrate for solution for infusion 100 mcgml (vial)

pfizer private limited - dexmedetomidine hcl eqv dexmedetomidine base - injection - 100 mcg/ml - dexmedetomidine hcl eqv dexmedetomidine base 100 mcg/ml

GLYPRESSIN FOR INJECTION 1 mgvial Singapur - angličtina - HSA (Health Sciences Authority)

glypressin for injection 1 mgvial

ferring pharmaceuticals private limited - terlipressin acetate - injection, powder, for solution - 1 mg/vial - terlipressin acetate 1 mg/vial

GLYPRESSIN solution for injection 1 mg8.5 ml Singapur - angličtina - HSA (Health Sciences Authority)

glypressin solution for injection 1 mg8.5 ml

ferring pharmaceuticals private limited - terlipressin 0.85 mg/8.5 ml eqv terlipressin acetate - injection, solution - 0.85 mg - terlipressin 0.85 mg/8.5 ml eqv terlipressin acetate 1 mg/8.5 ml

Glypressin 1mg, powder and solvent for solution for injection (5ml) Malta - angličtina - Medicines Authority

glypressin 1mg, powder and solvent for solution for injection (5ml)

ferring pharmaceuticals limited drayton hall, church road, west drayton ub7 7ps, united kingdom - terlipressin acetate - powder and solvent for solution for injection - terlipressin acetate 0.2 mg/ml - pituitary and hypothalamic hormones and analogues

Glypressin 1mg/8.5ml solution for injection Malta - angličtina - Medicines Authority

glypressin 1mg/8.5ml solution for injection

ferring pharmaceuticals limited drayton hall, church road, west drayton ub7 7ps, united kingdom - terlipressin acetate - solution for injection - terlipressin acetate 1 mg - pituitary and hypothalamic hormones and analogues

MIZART telmisartan 80mg tablet blister pack Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

mizart telmisartan 80mg tablet blister pack

alphapharm pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - mizart is indicated for: - treatment of hypertension - prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

MIZART telmisartan 40mg tablet blister pack Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

mizart telmisartan 40mg tablet blister pack

alphapharm pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - mizart is indicated for: - treatment of hypertension - prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

PHARMACOR TELMISARTAN telmisartan 80 mg tablets blister pack Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pharmacor telmisartan telmisartan 80 mg tablets blister pack

pharmacor pty ltd - telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: povidone; crospovidone; sodium hydroxide; lactose monohydrate; meglumine; colloidal anhydrous silica; magnesium stearate - telmisartan is indicated for:,treatment of hypertension ,prevention of cardiovascular morbidity and mortality in patients 55 years or older with,coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic,attack or high risk diabetes with evidence of end organ damage.